Vitro, S.A.B. de C.V.
VITOF
$0.66
-$0.01-1.49%
OTC PK
| 09/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 72.11M | 79.16M | 80.97M | 81.00M | 622.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 72.11M | 79.16M | 80.97M | 81.00M | 622.38M |
| Cost of Revenue | 42.16M | 40.69M | 40.94M | 41.00M | 462.24M |
| Gross Profit | 29.95M | 38.47M | 40.03M | 40.00M | 160.14M |
| SG&A Expenses | 24.99M | 28.49M | 29.94M | 30.00M | 117.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.16M | -7.73M | 3.23M | 3.00M | -1.65M |
| Total Operating Expenses | 65.99M | 61.46M | 74.11M | 74.00M | 577.77M |
| Operating Income | 6.12M | 17.70M | 6.86M | 7.00M | 44.61M |
| Income Before Tax | -36.03M | 28.58M | -2.68M | -3.00M | 34.98M |
| Income Tax Expenses | -1.57M | 9.71M | -887.00K | -1.00M | -834.00K |
| Earnings from Continuing Operations | -34.46M | 18.86M | -1.80M | -2.00M | 35.81M |
| Earnings from Discontinued Operations | -- | 69.44M | 16.10M | 16.00M | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 43.00K | 44.00K | -- | 140.00K |
| Net Income | -34.46M | 88.34M | 14.35M | 14.00M | 35.95M |
| EBIT | 6.12M | 17.70M | 6.86M | 7.00M | 44.61M |
| EBITDA | 9.93M | 56.87M | 46.03M | 46.17M | 81.46M |
| EPS Basic | -0.07 | 0.20 | 0.03 | 0.03 | 0.08 |
| Normalized Basic EPS | -0.05 | 0.04 | 0.00 | -- | 0.05 |
| EPS Diluted | -0.07 | 0.20 | 0.03 | 0.03 | 0.08 |
| Normalized Diluted EPS | -0.05 | 0.04 | 0.00 | -- | 0.05 |
| Average Basic Shares Outstanding | 492.26M | 437.19M | 478.33M | 470.03M | 449.38M |
| Average Diluted Shares Outstanding | 492.26M | 437.19M | 478.33M | 470.03M | 449.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | 83.45% |